1Inda MM, Perot C, Guillaud-Bataille M, et al. Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system[J]. Histopathology, 2005,7(6):631-637.
2Maher EA, Fumari FB, Bachoo RM, et al. Malignant glioma genetics and biology of a grave matter[J]. Genes Dev, 2001,15 (11):1311-1333.
3Rossi MR, La Duca J, Matsui S, et al. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme[J]. Genes Chromosomes Cancer, 2005,4(4): 392-404.
5Gresner SM, Rieske P, Wozniak K, et al. Molecular analysis of chromosome 1.10 and 19 abnormalities in human oligadendroglial tumors relationship between frequency of LOH grade age and gender[J]. Clin Neuropathol, 2006,25(1):18-24.
8Verdone L, Agricola E, Caserta M, et al. Histone acetylation in gene regulation[J]. Brief Funct Genomic Proteomic, 2006,5 (3): 209-221.
9Robert V J, Vastenhouw NL, Plasterk RH. RNA interference, transposon si!encing and cosuppression in the caenorhabditis elegans germ line: similarities and differences[J]. Cold Spring Harb Syrup Quant Biol, 2006,5(3):209-221.
10Wiendl H, Mitsdoerffer M, Hofmeister V, et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape[J]. J Immunol, 2002,168(9):4772- 4780.
6Ahluwalia A,Yan P,Hurteau JA.et al.DNA methylation and ovarian cancer.I.Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.Gynecol Oncol,2001,82(2): 261-268.
7Tost J,Schatz P,Schuster M.et al.Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry.Nucleic Acids Res,2003,31(9): e50.
8El-Osta A.The rise and fall of genomic methylation in cancer.Leukemia,2004, 18(2): 233-237.
9Brown R,Strathdee G.Epigenomics and epigenetic therapy of cancer.Trends Mol Med,2002,8(suppl 4): 43-48.
10Strathdee G,Brown R.Epigenetic cancer therapies: DNA methyltransferase inhibitors.Expert Opin Investig Drugs,2002,11(6): 747-754.
2Kim JW, Kim WC, Cho JH, et al.A multimodal approach including craniospinal irradiation improves the treatment outcome of high- risk intracranial nongerminomatous germ cell tumors[J]. Int J Radiat Oncol Biol Phys, 2012 Nov 1;84(3): 625-631.
3Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics[ J].CA Cancer] Clin,2005,55 (2):74-108.
4Taniguchi S, Narumoto J, Shibata K, et al.Treatment in a ward forelderly patients with dementia in Japan.[ J] .Neuropsychiatr DisTreat,2013,9: 357-363.
5Li W, Wait SD,Ogg RJ,et al.Functional magnetic resonance ima-ging of the visual cortex performed in children under sedation to assist in presurgical planning[J].J Neurosurg Pediatr,2013,11(4): 14-15.
6JanzerRC. Neuropathology and molecular pathologyofgliomas[J].Revue Medicale Suisse,2009,(211):1501-1504.
9Hoshino T,Wilson CB. The cell kinetics of gliomas[A].North Holland:Biomedical Press,1979.105.
10Kapp JP,Sanford RA. Neurological deficit after carotid infusion of cisplat in and BCNU for malignant gliomas:an analysis of risk factors[J].Neurosurgery,1986,(05):779-783.
